TPX2 and adrenal cortex carcinoma: In ACC, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD, PRAD, SARC, THCA, and UCEC, patients with high TPX2 expression experienced shorter PFS (Figure 3(d)).